SEC Form 4 · accession 0001645627-17-000112
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 25, 2017
Accepted (ET)
Aug 29, 2017 · 1:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0234 | A | 22,728,889 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0235 | A | 22,731,889 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0229 | A | 22,734,889 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0235 | A | 22,737,889 | D | |
| Common Stock | Aug 25, 2017 | P | 5,000 | $0.0235 | A | 22,742,889 | D | |
| Common Stock | Aug 25, 2017 | P | 5,000 | $0.0235 | A | 22,747,889 | D | |
| Common Stock | Aug 25, 2017 | P | 5,000 | $0.0235 | A | 22,752,889 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0234 | A | 22,755,889 | D | |
| Common Stock | Aug 25, 2017 | P | 5,000 | $0.0235 | A | 22,760,889 | D | |
| Common Stock | Aug 25, 2017 | P | 300 | $0.0252 | A | 22,761,189 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0252 | A | 22,764,189 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0249 | A | 22,767,189 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0258 | A | 22,770,189 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0258 | A | 22,773,189 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0258 | A | 22,776,189 | D | |
| Common Stock | Aug 25, 2017 | P | 3,000 | $0.0259 | A | 22,779,189 | D | |
| Common Stock | Aug 28, 2017 | P | 5,000 | $0.0271 | A | 22,784,189 | D | |
| Common Stock | Aug 28, 2017 | P | 3,000 | $0.0262 | A | 22,787,189 | D | |
| Common Stock | Aug 28, 2017 | P | 3,000 | $0.0262 | A | 22,790,189 | D | |
| Common Stock | Aug 28, 2017 | P | 4,530 | $0.0261 | A | 22,794,719 | D | |
| Common Stock | Aug 28, 2017 | P | 470 | $0.0262 | A | 22,795,189 | D | |
| Common Stock | Aug 28, 2017 | P | 3,000 | $0.0261 | A | 22,789,189 | D |
Table II — derivative securities
No Table II lines on this filing.